000 01235 a2200337 4500
005 20250517152921.0
264 0 _c20180326
008 201803s 0 0 eng d
022 _a1950-6007
024 7 _a10.1016/j.biopha.2017.04.105
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAlMatar, Manaf
245 0 0 _aNew drugs for the treatment of Mycobacterium tuberculosis infection.
_h[electronic resource]
260 _bBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
_cJul 2017
300 _a546-558 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAntitubercular Agents
_xpharmacology
650 0 4 _aDrug Delivery Systems
650 0 4 _aDrug Repositioning
650 0 4 _aHumans
650 0 4 _aMycobacterium tuberculosis
_xdrug effects
650 0 4 _aRNA, Antisense
_xtherapeutic use
650 0 4 _aTuberculosis
_xdrug therapy
700 1 _aAlMandeal, Husam
700 1 _aVar, Işıl
700 1 _aKayar, Begüm
700 1 _aKöksal, Fatih
773 0 _tBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
_gvol. 91
_gp. 546-558
856 4 0 _uhttps://doi.org/10.1016/j.biopha.2017.04.105
_zAvailable from publisher's website
999 _c27151895
_d27151895